PDGFRB and liver disorder: Here, we present the pharmacological characterization of [68Ga]Ga-DOTA-Cys-ATH001 in preparation for clinical translation and further confirm PDGFRß as a biomarker of activated HSCs in liver disease by single cell sequencing.